GILD
Gilead Sciences Inc.
$89.76
Earnings Summary
Revenue | $7545Mn |
Net Profits | $1253Mn |
Net Profit Margins | 16.61% |
Highlights
Gilead Sciences Inc.’s revenue jumped 7.02% since last year same period to $7545Mn in the Q3 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 8.58% jump in its revenue since last 3-months.
Gilead Sciences Inc.’s net profit fell -42.52% since last year same period to $1253Mn in the Q3 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated -22.37% fall in its net profits since last 3-months.
Gilead Sciences Inc.’s net profit margin fell -46.29% since last year same period to 16.61% in the Q3 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated -28.5% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Gilead Sciences Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 1.55 |
EPS Estimate Current Year | 1.55 |
Highlights
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.55 - a -3.13% fall from last quarter’s estimates.
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.55.
Key Ratios
Key ratios of the Gilead Sciences Inc. post its Q3 2024 earnings
Earning Per Share (EPS) | 2.02 |
Dividend Per Share (DPS) | 0.77 |
Highlights
Gilead Sciences Inc.’s earning per share (EPS) fell -11.79% since last year same period to 2.02 in the Q3 2024. This indicates that the Gilead Sciences Inc. has generated -11.79% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Gilead Sciences Inc. declared 0.77 dividend per share during the earnings announcement for Q3 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-08 | 1.6 | 2.01 | 25.62% |
2024-05-08 | -1.49 | -1.32 | 11.41% |
2024-11-12 | 1.55 | 2.02 | 30.32% |
₹0 US Stocks a/c Opening Fee